Contribution of infliximab population pharmacokinetic model for dose optimization in ulcerative colitis patients.
Saved in:
| Title: | Contribution of infliximab population pharmacokinetic model for dose optimization in ulcerative colitis patients. |
|---|---|
| Authors: | Santacana Juncosa E; Farmacia, Hospital Universitari de Bellvitge, España., Padullés Zamora A; Farmacia, Hospital de Bellvitge, España., Colom Codina H; Departamento de Farmacia y Tecnología Farmacéutica, Facultad de Farmacia (Universidad de Barcelona), España., Rodríguez Alonso L; Aparato digestivo, Hospital de Bellvitge, España., Guardiola Capo J; Hospital Universitari Bellvitge. Idibell. Hospitalet de Llobregat, Barcelona., Bas Minguet J; Hospital Universitari Bellvitge. Idibell. Hospitalet de Llobregat, Barcelona., Padullés Zamora N; FARMACIA, Hospital Universitari Bellvitge. Idibell. Hospitalet de Llobregat, Barcelona, ESPAÑA. |
| Source: | Revista espanola de enfermedades digestivas [Rev Esp Enferm Dig] 2016 Feb; Vol. 108 (2), pp. 104-5. |
| Publication Type: | Letter; Comment |
| Journal Info: | Publisher: Aran Ediciones Country of Publication: Spain NLM ID: 9007566 Publication Model: Print Cited Medium: Internet ISSN: 1130-0108 (Print) Linking ISSN: 11300108 NLM ISO Abbreviation: Rev Esp Enferm Dig Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
